Items Tagged ‘NUVIGIL’

November 3, 2009

Mayo Clinic Proceedings Publishes Study of NUVIGIL in Patients with Shift Work Disorder

By Kelley Luckstein

Cephalon, Inc. (Nasdaq: CEPH) today announced that the  November issue of Mayo Clinic Proceedings has published data from a pivotal Phase III trial demonstrating that NUVIGIL® (armodafinil) Tablets [C-IV] significantly improved wakefulness throughout the shift in patients with excessive sleepiness associated with shift work disorder (SWD). NUVIGIL, the longer-lasting isomer of modafinil, is indicated to […]

View full entry

Tags: Mayo Clinic Proceedings, NUVIGIL